0000921895-20-002114.txt : 20200806 0000921895-20-002114.hdr.sgml : 20200806 20200806162040 ACCESSION NUMBER: 0000921895-20-002114 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200803 FILED AS OF DATE: 20200806 DATE AS OF CHANGE: 20200806 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Harper Brian James CENTRAL INDEX KEY: 0001700373 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36435 FILM NUMBER: 201082001 MAIL ADDRESS: STREET 1: 6680 GUNPARK DRIVE STREET 2: SUITE 202B CITY: BOULDER STATE: CO ZIP: 80301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HARPER ASSET MANAGEMENT LLC CENTRAL INDEX KEY: 0001586910 STATE OF INCORPORATION: GA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36435 FILM NUMBER: 201082002 BUSINESS ADDRESS: STREET 1: 2945 S CENTER GREEN CT STREET 2: G215 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 404-451-7432 MAIL ADDRESS: STREET 1: 2945 S CENTER GREEN CT STREET 2: G215 CITY: BOULDER STATE: CO ZIP: 80301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pearce Michael Cooper CENTRAL INDEX KEY: 0001413616 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36435 FILM NUMBER: 201082003 MAIL ADDRESS: STREET 1: 213 RHODODENDRON DRIVE CITY: CHAPEL HILL STATE: NC ZIP: 27517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COUCHMAN JONATHAN CENTRAL INDEX KEY: 0001265094 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36435 FILM NUMBER: 201082004 MAIL ADDRESS: STREET 1: 630 FIFTH AVENUE STREET 2: SUITE 2260 CITY: NEW YORK STATE: NY ZIP: 10020 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Couchman Family Fund CENTRAL INDEX KEY: 0001737322 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36435 FILM NUMBER: 201082005 BUSINESS ADDRESS: STREET 1: 630 FIFTH AVENUE, SUITE 2260 CITY: NEW YORK STATE: NY ZIP: 10020 BUSINESS PHONE: (212) 729-4962 MAIL ADDRESS: STREET 1: 630 FIFTH AVENUE, SUITE 2260 CITY: NEW YORK STATE: NY ZIP: 10020 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Xstelos Corp. CENTRAL INDEX KEY: 0001571659 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36435 FILM NUMBER: 201082006 BUSINESS ADDRESS: STREET 1: 630 FIFTH AVENUE STREET 2: SUITE 2260 CITY: NEW YORK STATE: NY ZIP: 10020 BUSINESS PHONE: 212.729.4962 MAIL ADDRESS: STREET 1: 630 FIFTH AVENUE STREET 2: SUITE 2260 CITY: NEW YORK STATE: NY ZIP: 10020 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Myrexis, Inc. CENTRAL INDEX KEY: 0001459450 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36435 FILM NUMBER: 201082007 BUSINESS ADDRESS: STREET 1: 600 FIFTH AVENUE, 2ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10020 BUSINESS PHONE: 801-214-7800 MAIL ADDRESS: STREET 1: 600 FIFTH AVENUE, 2ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10020 FORMER NAME: FORMER CONFORMED NAME: Myriad Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20090324 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000727510 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222372868 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20 COMMERCE DRIVE, SUITE 135 CITY: CRANFORD STATE: NJ ZIP: 07016 BUSINESS PHONE: 732-980-4500 MAIL ADDRESS: STREET 1: 20 COMMERCE DRIVE, SUITE 135 CITY: CRANFORD STATE: NJ ZIP: 07016 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060324 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICALS INC DATE OF NAME CHANGE: 20021211 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICAL INC DATE OF NAME CHANGE: 20021210 3 1 form305735004_08062020.xml OWNERSHIP DOCUMENT X0206 3 2020-08-03 0 0000727510 ENZON PHARMACEUTICALS, INC. ENZN 0001265094 COUCHMAN JONATHAN 600 FIFTH AVENUE 2ND FLOOR NEW YORK NY 10020 0 0 1 0 0001737322 Couchman Family Fund 600 FIFTH AVENUE 2ND FLOOR NEW YORK NY 10020 0 0 1 0 0001571659 Xstelos Corp. 1105 NORTH MARKET STREET SUITE 1300 WILMINGTON DE 19801 0 0 1 0 0001459450 Myrexis, Inc. 600 FIFTH AVENUE 2ND FLOOR NEW YORK NY 10020 0 0 1 0 0001700373 Harper Brian James 2248 MARINER DR. LONGMONT CO 80503 0 0 0 1 See explanation of responses 0001586910 HARPER ASSET MANAGEMENT LLC 2248 MARINER DR. LONGMONT CO 80503 0 0 0 1 See explanation of responses 0001413616 Pearce Michael Cooper 193 AUDUBON TRAIL CASHIERS NC 28717 0 0 0 1 See explanation of responses Common Stock, par value $0.01 per share 4717666 I By Jonathan Couchman Common Stock, par value $0.01 per share 400000 I By Couchman Family Fund Common Stock, par value $0.01 per share 2100524 I By Xstelos Corp. Common Stock, par value $0.01 per share 633264 I By Myrexis, Inc. Common Stock, par value $0.01 per share 1667294 I By Harper Asset Management LLC Common Stock, par value $0.01 per share 0 I By Michael Pearce This Form 3 is filed jointly by Jonathan Couchman ("Mr. Couchman"), Couchman Family Fund (the "Foundation"), Xstelos Corp. ("Xstelos") and Myrexis, Inc. ("Myrexis"), Brian Harper, Harper Asset Management, LLC ("HAM"), and Michael Pearce, (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons expressly disclaims beneficial ownership of the Shares reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such Shares for purposes of Section 16 or for any other purpose. Represents shares owned directly by Mr. Couchman. As the sole trustee of the Foundation, Mr. Couchman may be deemed to beneficially own the Shares owned by the Foundation. As the Chief Executive Officer of Xstelos, Mr. Couchman may be deemed to beneficially own the shares of Common Stock owned by Xstelos. As the Chief Executive Officer of Myrexis, Mr. Couchman may be deemed to beneficially own Shares of Common Stock owned by Myrexis. Represents Shares owned directly by the Foundation. Mr. Couchman is the sole trustee of the Foundation. By virtue of this relationship, Mr. Couchman may be deemed to beneficially own the Shares owned directly by the Foundation, however he has no pecuniary interest in such Shares. Represents Shares owned directly by Xstelos. Mr. Couchman is the controlling shareholder and Chief Executive Officer of Xstelos. By virtue of these relationships, Mr. Couchman may be deemed to beneficially own the Shares owned directly by Xstelos. Mr. Couchman expressly disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein. Represents Shares owned directly by Myrexis. Mr. Couchman is Chief Executive Officer of Myrexis. By virtue of this relationship, Mr. Couchman may be deemed to beneficially own the Shares owned directly by Myrexis. Mr. Couchman expressly disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein. Represents shares owned directly by HAM. Mr. Harper is the President of HAM. By virtue of this relationship, Mr. Harper may be deemed to beneficially own the Shares owned directly by HAM. Mr. Harper expressly disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein. Represents shares owned directly by Michael Pearce. Mr. Pearce expressly disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein. /s/ Jonathan Couchman 2020-08-06 Couchman Family Fund; By: /s/ Jonathan Couchman, Trustee 2020-08-06 Xstelos Corp.; By: /s/ Jonathan Couchman, Chief Executive Officer 2020-08-06 Myrexis, Inc.; By: /s/ Jonathan Couchman, Chief Executive Officer 2020-08-06 /s/ Jonathan Couchman, attorney-in-fact for Brian Harper 2020-08-06 Harper Asset Management, LLC; By: /s/ Brian Harper 2020-08-06 /s/ Jonathan Couchman, attorney-in-fact for Michael Pearce 2020-08-06